MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 (vol 35, pg 6189, 2016)

L. Venturutti,R. I. Cordo Russo,M. A. Rivas,M. F. Mercogliano,F. Izzo,R. H. Oakley,M. G. Pereyra,M. De Martino,C. J. Proietti,P. Yankilevich,J. C. Roa,P. Guzman, E. Cortese, D. H. Allemand, T. H. Huang,E. H. Charreau,J. A. Cidlowski,R. Schillaci,P. V. Elizalde

ONCOGENE（2023）

引用 0|浏览6

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要